Search for: "E.I. DU PONT DE NEMOURS " Results 101 - 120 of 211
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Mar 2014, 8:40 am by Lindsey A. Zahn
 In re E.I. du Pont de Nemours & Co., 476 F.2d 1357, 177 USPQ 563 (CCPA 1973). [read post]
17 Oct 2013, 5:00 am by Bexis
For some reason, we recently found ourselves comparing our favorite defenses to our favorite rock bands. [read post]
6 Aug 2013, 8:36 am by Lawrence B. Ebert
A post at Biomass Mag on the latest Gevo/Butamax court decision includes the text:According the SEC filing, the court ruling is not material to the business of Gevo and is not material to any of the company’s other pending litigation cases with Butamax.A press release issued by Butamax notes that the court granted its summary judgment motion for invalidity of the [Gevo] ‘375 patent,Hmmm, a ruling that claims of a U.S. patent to Gevo are invalid is "not material to the business of Gevo"? … [read post]
30 Jul 2013, 1:06 pm
., Coudert Brothers Regina Pisa, Goodwin Procter John Quinn, Quinn Emanuel Urquhart & Sullivan Ralph Savarese, Howrey Clinton Stevenson, Latham & Watkins Law Firm Values Hillary Rodham Clinton, ABA Commission on Women in the Profession Esther Lardent, Pro Bono Institute Jonathan Lippman, New York State Chief Judge Robert MacCrate, ABA Task Force on Law Schools and The Profession David Morley, Allen & Overy Roderick Palmore, Leadership Council on Legal Diversity Thomas… [read post]
5 Jul 2013, 5:00 am by Bexis
If somebody were to ask us whether as a general proposition it’s relevant to the presentation of a product liability case about a prescription medical product that the FDA had approved/cleared the product and the defendant had complied with FDA regulations, our immediate reaction would be “Duh, of course, it’s relevant. [read post]
20 Dec 2012, 5:12 am by Jon Gelman
The plan will go into effect as a modification of a permit, which legally requires the E.I. du Pont de Nemours & Company, Inc. to fund and perform the work. [read post]
6 Jul 2012, 7:29 pm by Lawrence B. Ebert
E.I. du Pont De Nemours & Co., 750 F.2d 1569, 1580 (Fed. [read post]
3 Jul 2012, 4:19 am by Sean Wajert
Du Pont De Nemours & Co., 48 So. 3d 976, 997 (Fla. 3d DCA 2010), which rejected the Second Restatement’s “consumer expectations” test as an independent basis for finding a design defect, determining instead that, after Kohler, the appropriate standard is the “risk-utility/risk-benefit” test articulated in Section 2 of the Third Restatement. [read post]